MENS (jyongbio.com) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan Jyong Biotech Limited (MENS)

Jyong Biotech Ltd (MENS) focuses on developing plant-based pharmaceuticals, attracting leading scientists with the opportunity for deep research and generous investments in science. However, the firm's success is constrained by fierce competition in narrow niches and high risks of clinical trial failures. The current indicator stands at -5.93, and the market capitalization trend confirms this micro-cap biotech's dependence on external funding due to a lack of profitable products.

MENS Jyong Bio: Nilai Pasar marang Nilai Buku ing interval 18.06.2025 - 29.10.2026
Produk asli Jyong Biotech Corp

This indicator determines the market premium over the net asset value, measuring the premium investors are willing to pay for every dollar of book capital. By analyzing the current ratio of the company's value to its book capitalization, one can assess the impact of ESG standards and bioethics at Jyong Biotech Ltd (MENS) on business capitalization, where an increase in the metric reflects market recognition of the issuer's environmental innovation efficiency.

Pesaing utama

Haleon plc - Rasio Nilai Pasar marang Nilai Buku|KVUE (kenvue.com) - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Verona Pharma VRNA|Kapitalisasi Pasar marang Aset Bersih Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku Perrigo Corp (PRGO)|Rasio Kapitalisasi Pasar marang Nilai Buku ALVO (Alvotech)|liquidia.com - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Galapagos (GLPG)|ANIP: Nilai Pasar marang Nilai Buku|MNKD (MannKind Corp.) - Rasio Nilai Pasar marang Nilai Buku|Amphastar Corp (AMPH) - Rasio Kapitalisasi marang Aset Bersih|PCRX (Pacira BioSciences) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku ars-pharma.com (SPRY)|Theravance Biopharma, Inc. (TBPH) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku AQST (Aquestive Therapeutics Inc)|SCPH: Rasio Nilai Pasar marang Nilai Buku|TECX - Koefisien Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih Tonix Pharmaceuticals TNXP|SXTC - Multiplikator Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku eupraxiapharma.com EPRX|BioHarvest Sciences, Inc. (BHST) - Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku EXOZ (Invizyne Technologies, Inc.)|Koefisien Nilai Pasar marang Nilai Buku ORMP|Entera Bio Ltd. (ENTX) - Rasio Nilai Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku HYFT (ipatherapeutics.com)|Rasio Nilai Pasar marang Nilai Buku ABVC BioPharma, Inc. (ABVC)|CPIX - Multiplikator Kapitalisasi Pasar marang Nilai Buku|QNTM (Quantum BioPharma Limited) - Rasio Kapitalisasi marang Aset Bersih|FGEN: Koefisien Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku TELO|RANI (Rani Therapeutics Holdings, Inc.) - Koefisien Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Synergy CHC Corp. (SNYR)|Rasio Kapitalisasi marang Nilai Buku Rallybio Corp.|LEXX: Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Ekuitas Pulmatrix Corporation PULM|Rasio Kapitalisasi marang Aset Bersih Pheton Holdings|Nilai Pasar marang Nilai Buku Aptorum Group Ltd APM|LYRA - Rasio Kapitalisasi Pasar marang Nilai Buku|IBO - Rasio Nilai Pasar marang Nilai Buku|tnfpharma.com - Rasio Kapitalisasi Pasar marang Nilai Buku|YCBD (cbdMD) - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku PRFX (PainReform Ltd.)|Koefisien Nilai Pasar marang Nilai Buku Auris Medical (CYTO)|Rasio Kapitalisasi marang Aset Bersih Lipella Pharmaceuticals, Inc.|Multiplikator Kapitalisasi Pasar marang Nilai Buku OptiNose Inc (OPTN)|PIRS: Rasio Kapitalisasi Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku Procaps Group Corp PROC|PTPI: Rasio Kapitalisasi Pasar marang Nilai Buku|QLI - Rasio Kapitalisasi marang Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku ACELYRIN SLRN|Nilai Pasar marang Nilai Buku TFF Pharmaceuticals Inc.